Skip to main content

Dan Schell

Jun 3, 2026

14:20
So that's, that's what's been going on so far in terms of twen- so far in twenty twenty-six for Cell and Gene.
14:28
Yeah, I'd say for me, uh, it's what Ray had mentioned earlier about the real-time clinical trials initiative that the FDA just announced.
14:35
Um, to me, it's probably the biggest thing that's going on now and, you know, essentially you're getting-- You're sending data earlier to the FDA for them to review, and there's a lot of AI involved, cloud infrastructure, things like that, um, automatic extraction from EHRs.
14:51
So this is exciting because my industry has always been very slow in our development timelines.
15:00
In fact, the commissioner said forty-five percent of the current timeline is essentially dead time, you know, spent on paperwork and data cleaning and stuff like that.
15:08
So that's why they initiated this.
15:10
Um, so big advantages, you know, detect safety problems earlier, reduce delays, things like that.

32 MINS LATER

47:12
Dan, what's going on in Clinical Leader?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.